The Study
Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study
This study noticed that some heart attack patients with very low cholesterol still had more heart problems later. But it didn’t change their cholesterol — it just watched what happened. So we can’t say low cholesterol caused the problems — it just seems to happen together in very sick people.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
Even when heart attack patients get their bad cholesterol below the recommended level with strong meds, many still have another heart problem within a year.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 559 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this means current cholesterol targets aren't enough for the sickest patients; something else (like inflammation or artery damage) is still driving risk.
- 216.4% of patients with LDL-C below 55 mg/dL had another major heart event in 1 year; their risk was 51% higher than others, even after adjusting for age, diabetes, and inflammation.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
European Heart Journal
Year
2024
Authors
A. Denegri, S. Kraler, F. Wenzl, L. Raeber, B. Gencer, O. Muller, D. Nanchen, R. Klingenberg, T. Luescher
Related Content
Claims (10)
Patients with acute coronary syndrome who have low LDL cholesterol below 55 mg/dL are typically older, more likely to have had a prior heart attack or heart procedure, and show higher levels of systemic inflammation than those with higher LDL cholesterol.
Among heart attack patients with already low LDL cholesterol, higher levels of inflammation (hs-CRP), diabetes, and reduced kidney function are consistently linked to a greater chance of another heart event, showing that factors beyond cholesterol drive remaining risk.
Even when acute coronary syndrome patients reach the lowest recommended LDL cholesterol levels, about 1 in 6 still have a serious heart or brain event within a year, showing that current cholesterol goals do not fully prevent future cardiovascular events in these high-risk individuals.
In patients hospitalized for acute coronary syndrome with very low LDL cholesterol levels, 82.4% are taking high-dose statins, meaning their low cholesterol is due to medication, not natural variation or insufficient treatment.
Even when acute coronary syndrome patients reach the lowest recommended LDL cholesterol levels, about 1 in 6 still suffer a serious heart or brain event within a year, showing that current cholesterol goals do not fully prevent future cardiovascular events in the highest-risk patients.
In patients who have had a heart attack and already have very low LDL cholesterol levels, most are taking strong cholesterol-lowering drugs, meaning their low cholesterol is due to medication, not because they were at low risk to begin with.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.